MTO1 and breast cancer: The team then upgraded circRNA-MTO1 expression in BC cells resistant to monastrol and showed that circRNA-MTO1 not only reversed resistance but also had a synergetic effect when used with monastrol through binding to TRAF4 and inhibiting Eg5 protein (Liu et al., 2018).